Neogenomics (NEO) Shares Outstanding (2010 - 2026)

Neogenomics (NEO) has reported Shares Outstanding (Entity) for 17 consecutive years, with $127.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) fell 0.59% year-over-year to $127.9 million; the trailing twelve-month figure through Jun 2026 stood at $127.9 million (down 0.59% YoY), and the FY2025 full-year result was $129.0 million, up 0.66% from the prior year.
• Shares Outstanding (Entity) declined to $127.9 million in Q2 2026 per NEO's latest filing, from $129.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $129.7 million in Q1 2026 and bottomed at $124.7 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $127.6 million across 5 years, with a median of $127.6 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) gained 6.48% in 2022, then dropped 0.59% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $126.9 million in 2022, then increased by 0.36% to $127.4 million in 2023, then climbed by 0.61% to $128.1 million in 2024, then climbed by 0.66% to $129.0 million in 2025, then dropped by 0.83% to $127.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $127.9 million, $129.7 million, and $129.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.